Investors

Roche Half-Year Results 2025 Presentation

Roche has published its Half-Year Results for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 24 July 2025.

Please register to access the replay of the webcast
Presentation download
Presentation with appendix download

A blue-gloved hand delicately holds a small pink container with a QR code. Nearby are green, blue, and yellow containers on a white surface, indicating a scientific setting.

Roche’s Pharma Day 2025

Monday, 22nd September 2025, 09:00am BST

More details

3D illustration of colorful molecules with clustered blue and red spheres on a blurred brown-orange background, conveying a scientific and dynamic feel.

24 million

patients were treated with Roche medicines in 2024

30 billion

Roche Diagnostics test were delivered to customers worldwide in 2024

+1%

Core investments in research and development in 2024: CHF 13.2 billion

Product Pipeline

Why Invest

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Dr Thomas Schinecker

CEO Roche Group

Investor updates

View all updates

View ad-hoc announcements

Upcoming Investor events

View all events

UBS Precision Medicine Frontiers SummitInvestors

August 14, 2025 at 10:00 PDT | Dana Point, US

Add to calendar

22nd Annual Goldman Sachs European Medtech and Healthcare Services ConferenceInvestors

September 04, 2025 at 08:00 BST | London, UK

Add to calendar

Morgan Stanley 23rd Annual Global Healthcare ConferenceInvestors

September 09, 2025 at 08:30 EST | New York, US

Add to calendar

Nephron Napa Summit 2025Investors

September 17, 2025 at 10:00 PDT | Yountville, US

Add to calendar

Roche's Pharma Day 2025Investors

September 22, 2025 at 09:00 BST | London, UK

Add to calendar

Bank of America Global Healthcare ConferenceInvestors

September 25, 2025 at 10:00 BST | London, UK

Add to calendar

Latest reports

Smiling scientist in a lab coat and safety glasses holds a pipette in a modern laboratory. The setting conveys focus and innovation.

Half-year report 2025Investors

Microscopic image showing glowing blue cells clustered amidst intricate golden brown network, emitting a vibrant and scientific atmosphere.

Annual report 2024Investors

Finance Information Tool

Reporting

Download center

Share and Bond information

US investors

ESG Index

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.

View investor contact detail

Discover More

Roche Diagnostics news

Follow the most recent updates from our Diagnostics business

Genentech

Genentech has been delivering on the promise of biotechnology for over 35 years.

Sustainability at RocheAbout Roche

At Roche, our ambition lies not only in transforming healthcare, but also in our contributions to environmental protection, supply chain sustainability, social commitment and philanthropy.

Positions, policies & downloadsAbout Roche

Download our policies, guidelines, positions and other documents.

Frequently Asked QuestionsInvestors

We answer the Roche investors-related most frequently asked questions

PartneringInnovation

At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.